GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » ROIC %

TYK Medicines (HKSE:02410) ROIC % : -22.26% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. TYK Medicines's annualized return on invested capital (ROIC %) for the quarter that ended in Jun. 2024 was -22.26%.

As of today (2025-04-05), TYK Medicines's WACC % is 9.98%. TYK Medicines's ROIC % is -12.31% (calculated using TTM income statement data). TYK Medicines earns returns that do not match up to its cost of capital. It will destroy value as it grows.


TYK Medicines ROIC % Historical Data

The historical data trend for TYK Medicines's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines ROIC % Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24
ROIC %
-19.47 -20.03 -29.52

TYK Medicines Quarterly Data
Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Dec24
ROIC % Get a 7-Day Free Trial - - -18.56 -22.26 -

Competitive Comparison of TYK Medicines's ROIC %

For the Biotechnology subindustry, TYK Medicines's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TYK Medicines's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TYK Medicines's ROIC % distribution charts can be found below:

* The bar in red indicates where TYK Medicines's ROIC % falls into.


;
;

TYK Medicines ROIC % Calculation

TYK Medicines's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-304.326 * ( 1 - 0% )/( (1346.767 + 1692.66)/ 2 )
=-304.326/1519.7135
=-20.03 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=623.53 - 44.516 - ( 271.908 - max(0, 1074.548 - 306.795+271.908))
=1346.767

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=626.886 - 101.583 - ( 210.914 - max(0, 1422.983 - 255.626+210.914))
=1692.66

TYK Medicines's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Jun. 2024 is calculated as:

ROIC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-401.976 * ( 1 - 0% )/( (1803.212 + 1807.912)/ 2 )
=-401.976/1805.562
=-22.26 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=655.032 - 59.486 - ( 230.834 - max(0, 1490.739 - 283.073+230.834))
=1803.212

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=569.811 - 66.007 - ( 170.425 - max(0, 1517.631 - 213.523+170.425))
=1807.912

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TYK Medicines  (HKSE:02410) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, TYK Medicines's WACC % is 9.98%. TYK Medicines's ROIC % is -12.31% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


TYK Medicines ROIC % Related Terms

Thank you for viewing the detailed overview of TYK Medicines's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


TYK Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 1278 Mingzhu Road, Room 1403-2, Floor 14, Tower A, Changxing World Trade Building, Zhejiang Province, Changxing Economic Development Zone, Huzhou, CHN
TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization of pharmaceutical products.
Executives
Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng 2201 Interest of corporation controlled by you
Zhu Julia Ming 2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si 2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
He Chao 2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner

TYK Medicines Headlines

No Headlines